We are here for you during the COVID-19 pandemic. Discover ways to protect yourself. Coronavirus & MesotheliomaWe are here for you during the COVID-19 pandemic. Discover ways to protect yourself.Explore Now


The Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center houses experts in both lung and peritoneal cancers, giving them the capability to treat different forms of mesothelioma cancer. Their team implements advanced diagnostic and treatment methods to provide patients with options for treating their cancer. Specialists at the center use a new minimally invasive biopsy option known as electromagnet navigation bronchoscopy, which is guided by the computer and allows for multiple samples to be taken at once for better analysis.

Their peritoneal cancer care involves leading treatments in surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which work together to improve the quality and length of a patient’s life. The treatment works by removing the visible sites of cancer surgically, combined with instilling heated chemotherapy throughout the abdominal cavity. Their lung cancer treatment center utilizes advanced treatment options such as video-assisted thoracoscopic surgery (VATS) to deliver high-quality treatment for patients with lung conditions, including pleural mesothelioma.

Clinical trials are also available to patients who are eligible, providing more options for advanced treatment options. Palliative care and personal care are provided to patients at Nebraska Medicine to help them manage symptoms and hardships associated with their cancer diagnosis. Patients can also seek support groups, nutrition help, financial counseling and other support services through the center.


  • CAR T-Cell
  • Chemotherapy
  • Hyperthermic Intraperitoneal Chemotherapy
  • Immunotherapy
  • Palliative care
  • Radiation therapy
  • Surgical Cytoreduction


  • High Performing Hospital for Lung Cancer Surgery by U.S. News & World Report
  • Best Regional Hospital by U.S. News & World Report
  • Lung Cancer Alliance Screening Center of Excellence

Mesothelioma Clinical Trials at University of Nebraska Medical Center

The following clinical trials are in progress or actively recruiting participants at University of Nebraska Medical Center:

Integrated Cancer Repository for Cancer Research

Conditions: Multiple Myeloma, Pancreatic Neoplasms, Esophageal Neoplasms, Endometrial Neoplasms, Thyroid Neoplasms, Mesothelioma, Neuroendocrine Tumors, Salivary Gland Neoplasms, Anus Neoplasms, Gallbladder Neoplasms, Bile Duct Neoplasms, Oropharyngeal Neoplasms, Vaginal Neoplasms, Nasopharyngeal Neoplasms, Nasopharyngeal Carcinoma, Urethral Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Adenomatous Polyposis Coli, Testicular Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Intestinal Neoplasms, Hypopharyngeal Neoplasms, Penile Neoplasms, Ureteral Neoplasms, Peritoneal Neoplasms, Neoplasms, Plasma Cell, Paranasal Sinus Neoplasms, Duodenal Neoplasms, Neoplasms, Unknown Primary, Lip Neoplasms, Thymus Neoplasms, Paraproteinemias, Neoplasms

Last Updated: October 8, 2019

Status: Recruiting

Photo of University of Nebraska Medical Center

Get Help Contacting University of Nebraska Medical Center

    Privacy policy: All information is secure and will never be released



    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide

      Privacy policy: All information is secure and will never be released